NCT06242938View on ClinicalTrials.gov

Early Intensive Antihypertensive Treatment in High-Risk Population of intraCerebral Hemorrhage ExpanSion Predicted by Artificial Intelligence

NANot yet recruitingINTERVENTIONAL

Enrollment

680

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Cerebral Hemorrhage

Interventions

PROCEDURE

Early intensive antihypertensive treatment

"1. Treatment starts within 1 hour after randomization~2. SBP target:130-140 mmHg within 1 hour after treatment~3. The researchers can independently select oral + intravenous antihypertensive medications. Any type of antihypertensive drugs can be selected (eg. β-blokers, α-blockers, CCBs, ARBs/ACEIs, diuretic, etc.)."

All Listed Sponsors

lead

Beijing Tiantan Hospital

OTHER

NCT06242938 - Early Intensive Antihypertensive Treatment in High-Risk Population of intraCerebral Hemorrhage ExpanSion Predicted by Artificial Intelligence | Biotech Hunter | Biotech Hunter